Liquidia (LQDA) Cost of Revenue (2020 - 2026)
Liquidia (LQDA) recorded quarterly Cost of Revenue of $11.1 million in Q1 2026, up 75.19% quarter-over-quarter from $6.3 million in Q4 2025, and up 630.32% on a YoY basis from $1.5 million in Q1 2025.
Liquidia (LQDA) Cost of Revenue (2020 - 2026) Analysis & Trends
Liquidia's Cost of Revenue history runs 7 years deep, the most recent figure standing at $11.1 million for Q1 2026.
- In Q1 2026, Cost of Revenue rose 630.32% year-over-year to $11.1 million; the TTM figure through Mar 2026 stood at $18.5 million (up 211.79% YoY), while the FY2025 annual figure was $8.8 million, up 50.09% from the prior year.
- Cost of Revenue was $11.1 million for Q1 2026 at Liquidia, up from $6.3 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $11.1 million in Q1 2026 to a low of $205000.0 in Q2 2025.
- Historically, Cost of Revenue has averaged $1.9 million across 5 years, with a median of $878000.0 in 2025.
- The sharpest annual moves came in 2025 and 2026: Cost of Revenue sank 86.27% in 2025, then jumped 630.32% in 2026.
- A 5-year view of Cost of Revenue shows it stood at $694000.0 in 2022, then soared by 43.08% to $993000.0 in 2023, then jumped by 36.35% to $1.4 million in 2024, then soared by 367.06% to $6.3 million in 2025, then surged by 75.19% to $11.1 million in 2026.
- The last three Cost of Revenue figures came in at $11.1 million (Q1 2026), $6.3 million (Q4 2025), and $878000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 696.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 641.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 133.40 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 34.44 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 13.80 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 586.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 155.56 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 52.68 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 222.00 Mn |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 11.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.08 Mn |
| Mar 31, 2026 | 11.08 Mn |
| Dec 31, 2025 | 6.32 Mn |
| Dec 31, 2025 | 6.32 Mn |
| Sep 30, 2025 | 878,000.00 |
| Sep 30, 2025 | 878,000.00 |
| Jun 30, 2025 | 205,000.00 |
| Jun 30, 2025 | 205,000.00 |
| Mar 31, 2025 | 1.52 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | 1.47 Mn |
| Mar 31, 2024 | 1.47 Mn |
| Dec 31, 2023 | 993,000.00 |
| Dec 31, 2023 | 993,000.00 |